FDA Advises Repeat Testing to Reduce False Negative Results with COVID-19 Antigen Tests

COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. There are several important announcements for the month of October. You can find more details by clicking on the links below: 

On August 12, 2022, CDC alerted laboratories that the FDA issued a safety communication which advises people to perform repeat testing following a negative result with any COVID-19 antigen self-test. According to the FDA, COVID-19 antigen tests are less likely to detect the SARS-CoV-2 over nucleic acid amplification tests, such as PCR tests, especially early in infection.